WEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heartContinue Reading

FRIDAY, March 22, 2024 (HealthDay News) — Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, U.S. officials announced Thursday. The move comes after the U.S. Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label earlierContinue Reading

THURSDAY, Nov. 16, 2023 (HealthDay News) — If you need medical care, you’re more likely to skip it due to cost issues if you’re American than if you’re Australian, Canadian, British or French, a new report finds. Rising costs aren’t just causing poorer Americans to forgo needed care: The CommonwealthContinue Reading

THURSDAY, Oct. 19, 2023 (HealthDay News) — Americans with Down syndrome have a critical lifeline in Medicaid insurance, new research confirms. But the publicly funded insurance program will have to respond to rising numbers of older adults with Down syndrome, researchers say. “As more people with Down syndrome survive toContinue Reading